Research and Development

Showing 15 posts of 9594 posts found.

Bayer’s cardiovascular drug enters phase III

February 13, 2009 Research and Development, Sales and Marketing Bayer, cv

Bayer Schering Pharma has begun phase III trials of riociguat for treatment of two life-threatening conditions. Two trials will investigate …

Schering-Plough invests in Scotland drug discovery centre

February 6, 2009 Research and Development Merck, Scotland

Schering-Plough is to invest around $30 million in its early drug discovery work in Scotland. The company is investing a …

What are pharma’s core competencies?

February 5, 2009 Research and Development, Sales and Marketing pharma, strategy

Pharma has always been a highly profitable industry, and has historically been among the best performing industrial sectors in terms …

The Pharmafocus Interview: David Gillen

February 3, 2009 Research and Development Pfizer, UK, medicines access

David Gillen says he is a born optimist. But Pfizer UK’s medical director says this positive outlook doesn’t blind him …

Evidence HRT could reduce bowel cancer risk

February 2, 2009 Research and Development, Sales and Marketing HRT

A new study has found more evidence that hormone replacement therapy (HRT) may reduce a woman's risk of bowel cancer. …

The Pfizer-Wyeth merger

February 2, 2009 Research and Development, Sales and Marketing Pfizer, Wyeth, merger, sales

Before the merger, Pfizer faced a significant contraction in sales. Datamonitor's analysis suggests that the company's sales were declining at …

Working Life: Sam Knivett

January 23, 2009 Business Services, Research and Development Pfizer, UK, WL, Working Life, careers, compliance, drug safety

How did you find your way into your current role?From the age of 11 I wanted to be a farmer. …

Merck Serono’s multiple sclerosis drug on track for filing

January 23, 2009 Research and Development, Sales and Marketing MS, Merck Serono

Cladribine, a new oral treatment for multiple sclerosis is on track for a mid-2009 filing after the release of encouraging …

FDA finalises transgenic animals guide

January 23, 2009 Research and Development, Sales and Marketing FDA, US, reg

The route map for companies wishing to sell medicines made in genetically-engineered animals has been drawn up by the FDA. …

ReNeuron’s ground-breaking stem cell trial approved

January 22, 2009 Research and Development ReNeuron, stem cell

 UK biotech ReNeuron has been given the go-ahead for a ground-breaking stem cell clinical trial.The phase I trial of its …

UK Biotech: time for bold and affirmative action

January 22, 2009 Research and Development, Sales and Marketing BTG, Chris Collins, Christopher Evans, Neuropharm, Plethora, UK, biotech, pharma, strategy

Biotech leaders in the UK say the cash-stricken industry has reached ‘breaking point’, and have made an unprecedented plea for …

Pfizer announces R&D job losses

January 15, 2009 Research and Development Pfizer

Jobs losses at Pfizer's research and development centre in Sandwich, Kent look a certainty after the company announced cutbacks to …

Wellcome Trust backs epigenetics project

January 13, 2009 Research and Development epigenetics

A public-private partnership aiming to determine the three-dimensional structure of medically-relevant proteins and put them in the public domain has …
The Gateway to Local Adoption Series

Latest content